104 related articles for article (PubMed ID: 12147668)
1. Skin tags and the atherogenic lipid profile.
Twomey P
J Clin Pathol; 2002 Aug; 55(8):639; author reply 639. PubMed ID: 12147668
[No Abstract] [Full Text] [Related]
2. Skin tags and the atherogenic lipid profile.
Crook MA
J Clin Pathol; 2000 Nov; 53(11):873-4. PubMed ID: 11127274
[TBL] [Abstract][Full Text] [Related]
3. Skin tag (acrochordon) on labium majus in an infertile female.
Asad N; Mushtaq A; Bano R
J Coll Physicians Surg Pak; 2012 Sep; 22(9):613-4. PubMed ID: 22980625
[No Abstract] [Full Text] [Related]
4. The role of orexin A in metabolic disturbances in patients with acromegaly.
Jawiarczyk-Przybyłowska A; Bolanowski M
Endokrynol Pol; 2012; 63(6):463-9. PubMed ID: 23339004
[TBL] [Abstract][Full Text] [Related]
5. The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly.
Rizzo M; Montalto G; Rizvi AA; Christ ER
Angiology; 2012 Oct; 63(7):492-4. PubMed ID: 22371625
[No Abstract] [Full Text] [Related]
6. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
7. Letter re: Monitoring the response to treatment in acromegaly.
Ayuk J; Sheppard MC; Bates AS; Stewart PM
J Clin Endocrinol Metab; 2005 Aug; 90(8):4980. PubMed ID: 16087964
[No Abstract] [Full Text] [Related]
8. Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis.
Bolfi F; Neves AF; Boguszewski CL; Nunes-Nogueira VS
Eur J Endocrinol; 2019 Nov; 181(5):L5-L6. PubMed ID: 31539872
[No Abstract] [Full Text] [Related]
9. Effect of octreotide on plasma lipid metabolism in acromegaly.
Benito P; Calañas A; Galvez MA; Corpas MS
Ann Pharmacother; 1994 Oct; 28(10):1198. PubMed ID: 7841581
[No Abstract] [Full Text] [Related]
10. Biochemical monitoring of disease activity after surgery for acromegaly.
Shalet SM
J Clin Endocrinol Metab; 2004 Feb; 89(2):492-4. PubMed ID: 14764750
[No Abstract] [Full Text] [Related]
11. Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly?
Colao A; Lombardi G
J Clin Endocrinol Metab; 2008 Apr; 93(4):1181-2. PubMed ID: 18390816
[No Abstract] [Full Text] [Related]
12. Acromegaly: are new tests needed?
Spada A
J Endocrinol Invest; 2003 Feb; 26(2):104-5. PubMed ID: 12739734
[No Abstract] [Full Text] [Related]
13. Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study.
Colao A; Auriemma RS; Galdiero M; Lombardi G; Pivonello R
J Clin Endocrinol Metab; 2009 Oct; 94(10):3746-56. PubMed ID: 19622615
[TBL] [Abstract][Full Text] [Related]
14. Acrochordon: a cutaneous sign of carbohydrate intolerance.
Agarwal JK; Nigam PK
Australas J Dermatol; 1987 Dec; 28(3):132-3. PubMed ID: 3504146
[No Abstract] [Full Text] [Related]
15. Value of petrosal sinus sampling: coexisting acromegaly, empty sella and meningioma.
Yarman S; Minareci O
Neuroradiology; 2004 Dec; 46(12):1027-30. PubMed ID: 15580492
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
[TBL] [Abstract][Full Text] [Related]
17. The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
Karavitaki N; Fernandez A; Fazal-Sanderson V; Wass JA
Clin Endocrinol (Oxf); 2009 Dec; 71(6):840-5. PubMed ID: 19320648
[TBL] [Abstract][Full Text] [Related]
18. [Lipid metabolism in acromegaly].
Ovcharova N
Vutr Boles; 1977; 16(6):1-8. PubMed ID: 341530
[No Abstract] [Full Text] [Related]
19. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.
;
J Clin Endocrinol Metab; 2004 Jul; 89(7):3099-102. PubMed ID: 15240576
[No Abstract] [Full Text] [Related]
20. Treatment of acromegaly.
Utiger RD
N Engl J Med; 2000 Apr; 342(16):1210-1. PubMed ID: 10770989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
